Clinical Trial

Mg Alloy DrillPins in Hammertoe Deformity Correction

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, single-arm clinical feasibility study evaluating the safe application of a novel lean absorbable magnesium-zinc-calcium alloy (ZX00) drill pin (RemeOs™ DrillPin) for the surgical correction of hammertoe deformities. A total of 20 adult patients will be enrolled. All participants will receive the investigational implant without a comparator or control group. The study focuses on feasibility, safety, and functional outcomes following implantation.
Trial Details
NCT Number NCT07121790
Lead Sponsor Bioretec Ltd.
Conditions Hammertoe, Hammer Toe Syndrome
Enrollment 20 participants
Start Date 2025-08
Primary Completion 2028-01 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-14